News | Proton Therapy | April 18, 2016

First Proton Therapy Treatment Center Coming to South Florida

Offshoot of Delray Medical Center will use Varian ProBeam proton therapy system

Varian, proton therapy, ProBeam system, Delray Medical Center, South Florida

April 18, 2016 — Delray Medical Center, Delray Beach, Fla., has reached agreement with Proton International (PI) to build a one-room proton therapy treatment center serving the South Florida corridor.

Proton therapy, a form of radiation therapy, is a highly precise and effective treatment for many cancer tumors but without many of the side effects that often accompany treatment.

Delray will be among a select group of hospitals in the country to offer proton therapy using the most advanced technology available, a fully featured compact system with dynamic peak pencil beam scanning, developed by Varian Medical Systems.

“We are looking forward to offering this innovative treatment option at Delray Medical Center,” said Mark Bryan, CEO. “It is always our goal to incorporate new technologies and techniques that will make treatment safer and less invasive for our patients.”

“We are very pleased to team with Delray to assure broader access to this important cancer therapy. It will allow people to be treated in their community, close to family and friends,” said Chris Chandler, CEO of Proton International, which currently has proton centers under construction at Beaumont Hospital, Royal Oak, Mich., and the University Medical Center in Groningen, The Netherlands. “We selected Varian to be the proton system provider because Varian’s ProBeam system has unique capabilities making it the most complete single room proton system on the market.”

Proton therapy is particularly effective in treating solid cancer tumors, including tumors of the brain, spine, head and neck, lung, prostate, colon and some breast tumors. It is widely used to treat children with cancer because of its precision and lack of long-term side effects, as children are particularly sensitive to the effects of radiation therapy.

Pencil beam scanning gives physicians advanced options for delivering proton therapy precisely in order to minimize exposure to healthy tissue while delivering treatments. The scanning beam technology enables intensity-modulated proton therapy (IMPT) by adjusting dose levels on a spot-by-spot basis throughout the treatment area.

PI’s turnkey development significantly lowers project risk and provides access to long-term funding, making it easier and more affordable for hospitals, oncologists and other medical professionals to offer proton cancer therapy to patients in one- or two-room centers.

For more information: www.protonintl.com

Related Content

Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Women are more likely to be cured of cancer by radiotherapy but the side effects are worse.

Women are more likely to be cured of cancer by radiotherapy but the side effects are worse. Image by Mark Kostich

News | Radiation Therapy | March 30, 2020
March 30, 2020 — Women undergoing radiotherapy for
A new framework from an international team of experts aims to help protect patients and providers, and conserve protective equipment for frontline healthcare workers #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Prostate Cancer | March 30, 2020
March 30, 2020 — In the wake of the COVID-19 pan
Accuray Incorporated announced that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife M6 System in Missouri at their state-of-the-art David C. Pratt Cancer Center
News | Stereotactic Body Radiation Therapy (SBRT) | February 27, 2020
February 27, 2020 — Accuray Incorporated announced that Mercy
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy

An oxygen map image recovered from a mouse undergoing radiation therapy. The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy (red). Image courtesy of Brian Pogue, PhD

News | Radiation Therapy | February 03, 2020
February 3, 2020 — Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful.